10/25/17
The Advisory Committee on Immunization Practices (ACIP) gives their recommendation and preference of Shingvax vaccine over current shingles vaccine, Zostavax. This vote was due to the impressive 90% efficacy demonstrated by Shingvax. This information will be published in the upcoming issue of the Morbidity and Mortality Weekly Report. Read more